The 2024 AAPP Summit, a 2-day virtual event, will be held on October 10th and 11th. The Summit features 8 evidence-based sessions on emerging areas of practice and contemporary issues in psychiatric pharmacy. This interactive, virtual conference is co-sponsored with the Society of Pain and Palliative Care (SPPCP) and provides knowledge and tools to improve the comprehensive care of patients with mental health disorders. Psychiatric and pain pharmacists will find this content valuable regardless of the practice setting. Register now and join us to earn 10 hours of ACPE and BCPP recertification credit! Two grant supported sessions will also be available for an additional 2 hours of ACPE credit.
The Recertification Editorial Board has been hard at work finalizing a fantastic line-up of sessions:
Thursday, October 10
- Chronic Pain and Depression/Anxiety: Addressing the Cycle, presented by Audrey A. Abelleira, PharmD, BCPS, BCPP
- Managing Pain and Co-Occurring Opioid Use Disorder: Dispelling Myths to Improve Care, presented by Michelle Kirchbaum, PharmD, BCPP
- Impact of Social Determinants of Health on Psychotropic Long-Acting Injectable Access and Administration, grant supported by Otsuka America Pharmaceutical, Inc. and presented by Robert G. Sise, MD, MBA, MPH and Michelle Reinhardt, PharmD, BCPP
- Use of Psychedelics for the Treatment of Substance Use Disorders, presented by Christopher Nicholas, PhD
- Impact of Microaggressions on Practice, presented by John M. Allen, PharmD, BCPS, BCCCP, FCCM, FCCP
Friday, October 11
- Management of Attention-Deficit/Hyperactivity Disorder (ADHD): Considerations for Adults, presented by Daina L. Wells, PharmD, MBA, BCPP
- Street Medicine: Psychiatric Care for Individuals who are Unhoused, presented by James Withers, MD, FACP and Madeleine Lipshie-Williams, MD
- Treatment of Postpartum Depression: Focus on the Role and Clinical Considerations for Neuroactive Steroids, grant supported by Sage Therapeutics, Inc. and presented by Lauren M. Osborne, MD
- You and Me Versus ChatGPT: Assessing the Role of Artificial Intelligence in Health Care, presented by Charlotte Rosalind Blease, BSc, MA, PhD
- Benzodiazepine-Induced Neurological Dysfunction, presented by Jeff D. Gold, PharmD, BCPP and Alexis Ritvo, MD, MPH
This event is open to AAPP and SPPCP members and non-members and has special pricing for residents/fellows and students! Check out the schedule to join us virtually on October 10-11. Session recordings will be made available to registrants following the event.
Register Now
